Cited by 522Technology and Human Factors in Education and HealthAdvanced Biosensing Techniques and ApplicationsMetabolomics and Mass Spectrometry Studies

Enabling Technologies for Personalized and Precision Medicine

Open access
Ho, Dean, Quake, Stephen R., McCabe, Edward R.B., Chng, Wee Joo, Chow, Edward K., Ding, Xianting, Gelb, Bruce D., Ginsburg, Geoffrey S. +8 more·2020·Trends in Biotechnology

Abstract

Individualizing patient treatment is a core objective of the medical field. Reaching this objective has been elusive owing to the complex set of factors contributing to both disease and health; many factors, from genes to proteins, remain unknown in their role in human physiology. Accurately diagnosing, monitoring, and treating disorders requires advances in biomarker discovery, the subsequent development of accurate signatures that correspond with dynamic disease states, as well as therapeutic interventions that can be continuously optimized and modulated for dose and drug selection. This work highlights key breakthroughs in the development of enabling technologies that further the goal of personalized and precision medicine, and remaining challenges that, when addressed, may forge unprecedented capabilities in realizing truly individualized patient care.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tibtech.2019.12.021

Cites

209 of 209 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • As a result of these flaws, RCTs do not dynamically or accurately determine the best treatments and tailored regimens, which may change as patient behaviour and neurobiology evolves during treatment.

    “As a result of these flaws, RCTs do not dynamically or accurately determine the best treatments and tailored regimens, which may change as patient behaviour and neurobiology evolves during the course of treatment.41”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 212 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Ho, D., Quake, S. R., McCabe, E. R. B., Chng, W. J., Chow, E. K., Ding, X., Gelb, B. D., Ginsburg, G. S., Hassenstab, J., Ho, C.-M., Mobley, W. C., Nolan, G. P., Rosen, S. T., Tan, P., Yen, Y., & Zarrinpar, A.
Affiliations
  • National University of Singapore (SG)
  • Chan Zuckerberg Biohub San Francisco (US)
  • March of Dimes (US)
  • Shanghai Jiao Tong University (CN)
  • Icahn School of Medicine at Mount Sinai (US)
  • Duke University (US)
  • Washington University in St. Louis (US)
  • University of California, Los Angeles (US)
  • University of California San Diego (US)
  • Stanford University (US)
  • City Of Hope National Medical Center (US)
  • Taipei Medical University (TW)
  • University of Florida Health (US)
Corresponding author
  • Ho, Dean
  • McCabe, Edward R.B.
Venue
Trends in Biotechnology
Publisher
Elsevier BV
Published
2020-05
Volume
38
Issue
5
Pages
497-518
ISSN
0167-7799 (ISSN-L)
OpenAlex
W3001878481
Cited by
517
References
212
Citations by year
2026: 97 · 2025: 143 · 2024: 106 · 2023: 67 · 2022: 48 · 2021: 39 · 2020: 17
FWCI
7.24
Type
journal article
Language
en
Open access
Locations
  • Trends in biotechnology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • V Foundation for Cancer Research
  • National Research Foundation Singapore
  • Wallace H. Coulter Foundation
  • National Institutes of Health
  • Ministry of Education - Singapore
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Technology and Human Factors in Education and Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
Keywords
personalized medicine, precision medicine, biomarker discovery, disease signatures, personalized treatment, drug selection, dose optimization, enabling technologies, individualized care
MeSH terms
Artificial Intelligence, Diagnosis, Humans, Therapeutics, Biomarkers, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review